Comments on: Will Big Pharma get littler in HIV research? http://www.wisdomofwhores.com/2008/07/21/will-big-pharma-get-littler-in-hiv-research/ Of sex and science. Elizabeth Pisani's blog about HIV and other sundry things. Sat, 22 Nov 2008 18:24:27 +0000 http://wordpress.org/?v=2.6 By: Daniel Reeders http://www.wisdomofwhores.com/2008/07/21/will-big-pharma-get-littler-in-hiv-research/#comment-1175 Daniel Reeders Tue, 29 Jul 2008 01:07:34 +0000 http://www.wisdomofwhores.com/?p=453#comment-1175 I'd just like to point out quite a lot of the early research - finding and profiling candidate molecules - was never done by Big Pharma at all; it's done by boutique companies who might profile thousands of molecules to find a small handful of candidates to shop around to the bigger companies, who have the expertise and financial clout to run human trials and formulate pharmaceuticals in their final shape. I’d just like to point out quite a lot of the early research - finding and profiling candidate molecules - was never done by Big Pharma at all; it’s done by boutique companies who might profile thousands of molecules to find a small handful of candidates to shop around to the bigger companies, who have the expertise and financial clout to run human trials and formulate pharmaceuticals in their final shape.

]]> By: Roger http://www.wisdomofwhores.com/2008/07/21/will-big-pharma-get-littler-in-hiv-research/#comment-1145 Roger Thu, 24 Jul 2008 12:49:15 +0000 http://www.wisdomofwhores.com/?p=453#comment-1145 Late comment: I don't think the question is "how much is enough when we press commercial firms to lower prices?" but "where". Thailand issuing compulsory licensing for Efavirenz and other drugs triggered a big "hou ha" followed by a war of words (Read my take http://tinyurl.com/2z2sjg and more recently http://tinyurl.com/66buc9) The motivation behind that was not that much that the Big Pharma would be losing money (both HAART and the Thai market count for little in their profit) but that if nothing was done then other would follow suit. Other means big market share like China... Late comment: I don’t think the question is “how much is enough when we press commercial firms to lower prices?” but “where”. Thailand issuing compulsory licensing for Efavirenz and other drugs triggered a big “hou ha” followed by a war of words (Read my take http://tinyurl.com/2z2sjg and more recently http://tinyurl.com/66buc9)

The motivation behind that was not that much that the Big Pharma would be losing money (both HAART and the Thai market count for little in their profit) but that if nothing was done then other would follow suit.

Other means big market share like China…

]]> By: Lee Rudolph http://www.wisdomofwhores.com/2008/07/21/will-big-pharma-get-littler-in-hiv-research/#comment-1132 Lee Rudolph Mon, 21 Jul 2008 10:32:33 +0000 http://www.wisdomofwhores.com/?p=453#comment-1132 "And one of their most effective products is unpopular because it has to be injected rather than swallowed." Sounds like there's one very natural market for *that*, and an established cadre of sales people, too. Where's that entrepreneurial spirit, Roche? “And one of their most effective products is unpopular because it has to be injected rather than swallowed.”

Sounds like there’s one very natural market for *that*, and an established cadre of sales people, too. Where’s that entrepreneurial spirit, Roche?

]]>